Prospects in folate receptor-targeted radionuclide therapy
about
Nanoparticle ligand presentation for targeting solid tumorsSimple bioconjugate chemistry serves great clinical advances: albumin as a versatile platform for diagnosis and precision therapyDevelopment and evaluation of a new modular nanotransporter for drug delivery into nuclei of pathological cells expressing folate receptors.A Short-Term Biological Indicator for Long-Term Kidney Damage after Radionuclide Therapy in MiceInsight into nanoparticle cellular uptake and intracellular targetingThe potential and hurdles of targeted alpha therapy - clinical trials and beyond.Multifunctional mitoxantrone-conjugated magnetic nanosystem for targeted therapy of folate receptor-overexpressing malignant cells.Targeted alpha therapy using short-lived alpha-particles and the promise of nanobodies as targeting vehicle.Nanomedicines for cancer therapy: state-of-the-art and limitations to pre-clinical studies that hinder future developments.Continued rapid growth in (68) Ga applications: update 2013 to June 2014.Enhancing the therapeutic range of a targeted small-molecule tubulysin conjugate for folate receptor-based cancer therapy.Targeted Radionuclide Therapy: An Evolution Toward Precision Cancer TreatmentIn-vivo monitoring of anti-folate therapy in arthritic rats using [18F]fluoro-PEG-folate and positron emission tomography.Size of single-wall carbon nanotube affects the folate receptor-mediated cancer cell targeting.Preclinical evaluation of isostructural Tc-99m- and Re-188-folate-Gly-Gly-Cys-Glu for folate receptor-positive tumor targeting.Prospective of 68Ga Radionuclide Contribution to the Development of Imaging Agents for Infection and Inflammation.
P2860
Q27009522-4C86C4A4-AA94-472A-BC70-E739771A4EBCQ28397980-4CC02F8F-5CF0-4AB8-BC6F-A0DFE6F12494Q33627894-9E1E1A44-4427-431D-9BAD-93E7B7CB84B5Q33851549-60A81579-AACB-4444-A5C7-D338E293086DQ34127625-A0C6050A-2268-4F32-970D-95F606F8E240Q34399879-C857EF3E-E600-4926-BAE8-1CF062EC8486Q35292124-08B2B170-8834-4F84-8A77-882A85FC5448Q37085052-6722FAE8-1D1B-4557-B0EB-B3CF55BC6708Q38247299-C7B92565-D4C9-498E-B417-4F41886464B5Q38358666-A7EF9427-E779-4D70-83AA-277A0ACB7B19Q38815492-78150286-AB5C-4F98-9334-E20CFF612A45Q41475179-2D7D0835-493F-430C-AFCE-F3A0888A5ECFQ41808297-EF33442F-9E3C-46B1-9617-E3F360029C1EQ47191052-C99B3BE5-3478-43DA-A9DC-789F76BC17DCQ53166641-FF020230-28BA-4212-ADCB-B867325A53CAQ54257268-E3E5E065-3FFE-4077-96EA-228CA5251C9D
P2860
Prospects in folate receptor-targeted radionuclide therapy
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Prospects in folate receptor-targeted radionuclide therapy
@en
Prospects in folate receptor-targeted radionuclide therapy.
@nl
type
label
Prospects in folate receptor-targeted radionuclide therapy
@en
Prospects in folate receptor-targeted radionuclide therapy.
@nl
prefLabel
Prospects in folate receptor-targeted radionuclide therapy
@en
Prospects in folate receptor-targeted radionuclide therapy.
@nl
P2860
P356
P1476
Prospects in folate receptor-targeted radionuclide therapy
@en
P2093
Cristina Müller
P2860
P356
10.3389/FONC.2013.00249
P577
2013-09-24T00:00:00Z